BWV
NASDAQBlue Water Biotech Inc.
Latest news
25 items- INSIDERSEC Form 3 filed by new insider Singh Ajit3 - Onconetix, Inc. (0001782107) (Issuer)
- INSIDERSEC Form 3 filed by new insider Meier Thomas3 - Onconetix, Inc. (0001782107) (Issuer)
- SECSEC Form S-1 filed by Blue Water Biotech Inc.S-1 - Onconetix, Inc. (0001782107) (Filer)
- SECSEC Form PRE 14A filed by Blue Water Biotech Inc.PRE 14A - Onconetix, Inc. (0001782107) (Filer)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- SECSEC Form S-8 filed by Blue Water Biotech Inc.S-8 - Onconetix, Inc. (0001782107) (Filer)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- 13D/GSEC Form SC 13G/A filed by Blue Water Biotech Inc. (Amendment)SC 13G/A - Onconetix, Inc. (0001782107) (Subject)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- INSIDERNew insider Schiess Ralph claimed ownership of 269,749 shares (SEC Form 3)3 - Onconetix, Inc. (0001782107) (Issuer)
- 13D/GSEC Form SC 13G/A filed by Blue Water Biotech Inc. (Amendment)SC 13G/A - Onconetix, Inc. (0001782107) (Subject)
- INSIDERNew insider Bruhlmann Christian claimed ownership of 236,029 shares (SEC Form 3)3 - Onconetix, Inc. (0001782107) (Issuer)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- 13D/GSEC Form SC 13G filed by Blue Water Biotech Inc.SC 13G - Onconetix, Inc. (0001782107) (Subject)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits (Amendment)8-K/A - Onconetix, Inc. (0001782107) (Filer)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers Aclarion (NASDAQ:ACON) shares increased by 59.9% to $0.47 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Clene (NASDAQ:CLNN) stock rose 8.1% to $0.59. The market value of their outstanding shares is at $75.6 million. Acutus Medical (NASDAQ:AFIB) stock rose 6.83% to $0.21. The company's market cap stands at $6.1 million. Avinger (NASDAQ:AVGR) stock moved upwards by 5.55% to $2.85. The market value of their outstanding shares is at $3.6 million. Blue Water Biotech (NASDAQ:BWV) stock increased by 5.26% to $0.21. The company's market cap stands at $3.9 million. Biora Therapeutics (NASDAQ:BIOR) stock moved upwards by 5.11% to $1.23. The compa
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Biomerica (NASDAQ:BMRA) shares rose 54.5% to $1.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $25.7 million. Cingulate (NASDAQ:CING) stock increased by 33.33% to $2.84. The company's market cap stands at $2.6 million. Arcutis Biotherapeutics (NASDAQ:ARQT) stock increased by 31.14% to $3.2. The market value of their outstanding shares is at $302.0 million. Panbela Therapeutics (NASDAQ:PBLA) shares increased by 30.54% to $0.6. The market value of their outstanding shares is at $3.0 million. NRX Pharmaceuticals (NASDAQ:NRXP) shares rose 30.08% to $0.44. The company's market cap stands at $37.5 million. Alaunos Therapeutics (NASDAQ:TCRT)
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Onconetix, Inc. (0001782107) (Filer)
- PROnconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to ShareholdersCINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (NASDAQ:BWV) ("Onconetix" or the "Company") today issued the following shareholder letter from the Company's Chief Executive Officer, Dr. Neil Campbell. To Our Valued Shareholders, As 2023 draws to a close, I am eager to share with you the significant strides Onconetix, Inc. (formerly Blue Water Biotech, Inc.) has made in our journey towards becoming a leader in oncology. This past quarter has been transformative, marked by strategic shifts and notable achievements, all aimed at enhancing the value we bring to you as our shareholders. To reflect our recent achievements and renewed oncology focus, we have rebranded as Onconet
- SECBlue Water Biotech Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Blue Water Biotech, Inc. (0001782107) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Biomerica (NASDAQ:BMRA) shares rose 71.7% to $1.7 during Monday's pre-market session. The market value of their outstanding shares is at $28.5 million. Arcutis Biotherapeutics (NASDAQ:ARQT) shares rose 41.8% to $3.46. The market value of their outstanding shares is at $326.5 million. Alaunos Therapeutics (NASDAQ:TCRT) stock increased by 32.74% to $0.06. The company's market cap stands at $14.5 million. Akili (NASDAQ:AKLI) shares moved upwards by 29.46% to $0.54. The company's market cap stands at $42.2 million. Applied DNA Sciences (NASDAQ:APDN) stock moved upwards by 25.6% to $0.78. The company's market cap stands at $10.6 million. NRX Pharmaceuticals (NASDAQ:NRXP) shares rose
- NEWSBlue Water Biotech Acquires Proteomedix AG, A Private, Commercial-stage Diagnostics Oncology Company, In Stock Consideration; No Terms DisclosedThe acquisition of Proteomedix for all stock consideration provides its shareholders with an initial 19.9% ownership stake of Onconetix and introduced a new name for the combined Company: Onconetix, Inc. Two members of Proteomedix' leadership team will become executives of Onconetix.
BWV FAQ
6 questionsWhat does Blue Water Biotech Inc. do?
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in...Where does BWV stock trade?
Blue Water Biotech Inc. (BWV) is listed on NASDAQ.What sector and industry is BWV in?
Blue Water Biotech Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Blue Water Biotech Inc. go public?
Blue Water Biotech Inc. (BWV) completed its IPO in 2022.What companies are similar to BWV?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare BWV side-by-side with any of them on Quantisnow.How can I track BWV on Quantisnow?
Quantisnow aggregates Blue Water Biotech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BWV to receive live email and push alerts on every new disclosure.